Tandlægeselskabet Nikan2 Holding ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.5% 0.5% 0.5% 0.5% 0.5%  
Bankruptcy risk  7.4% 2.1% 6.1% 3.8% 3.8%  
Credit score (0-100)  34 67 37 50 50  
Credit rating  BBB A BBB BBB BBB  
Credit limit (kDKK)  0.0 0.6 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  -186 -142 -233 -157 -220  
EBITDA  -1,344 -1,579 -1,705 -1,405 -1,470  
EBIT  -3,177 -1,896 -2,077 -1,954 -2,162  
Pre-tax profit (PTP)  -192.5 3,864.6 -2,781.3 356.6 638.4  
Net earnings  -494.5 3,013.8 -2,169.4 290.0 494.1  
Pre-tax profit without non-rec. items  -192 3,865 -2,781 357 638  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  5,788 465 760 2,292 1,744  
Shareholders equity total  7,694 10,597 8,314 8,490 8,866  
Interest-bearing liabilities  858 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  15,156 17,736 14,597 14,984 15,506  

Net Debt  -5,888 -14,587 -9,669 -8,572 -9,422  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -186 -142 -233 -157 -220  
Gross profit growth  -905.6% 23.7% -63.6% 32.5% -40.0%  
Employees  1 0 1 1 1  
Employee growth %  0.0% -100.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  15,156 17,736 14,597 14,984 15,506  
Balance sheet change%  -0.0% 17.0% -17.7% 2.7% 3.5%  
Added value  -1,344.4 -1,578.8 -1,705.4 -1,582.2 -1,470.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -3,665 -5,745 590 839 -1,384  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -4.0 -5.0 -5.0 -5.0 -5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  1,706.2% 1,334.2% 893.3% 1,244.4% 984.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  2.4% 27.3% 9.1% 6.3% 8.1%  
ROI %  3.9% 45.4% 15.4% 11.1% 14.3%  
ROE %  -6.2% 33.0% -22.9% 3.5% 5.7%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  50.8% 59.7% 57.0% 56.7% 57.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  438.0% 923.9% 567.0% 610.2% 640.7%  
Gearing %  11.2% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  62.5% 145.2% 0.0% 0.0% 0.0%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  1.3 2.3 1.8 1.6 1.6  
Current Ratio  1.3 2.3 1.9 1.7 1.8  
Cash and cash equivalent  6,746.2 14,587.4 9,669.1 8,572.4 9,421.6  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -3,410.8 -4,839.1 6.0 -3,502.0 -3,463.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  -1,344 0 -1,705 -1,582 -1,470  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -1,344 0 -1,705 -1,405 -1,470  
EBIT / employee  -3,177 0 -2,077 -1,954 -2,162  
Net earnings / employee  -495 0 -2,169 290 494